GHS: Health hazards Classification and labelling including basic toxicology

Size: px
Start display at page:

Download "GHS: Health hazards Classification and labelling including basic toxicology"

Transcription

1 GHS: Health hazards Classification and labelling including basic toxicology Lennart Dock Swedish Chemicals Agency ITP299EU September - 7 October 2014

2 Alle Ding sind Gift und nichts ohn Gift; alein die Dosis macht, das ein Ding kein Gift ist Response 100% Dose Paracelsus (Theophrastus Bombastus Philippus Aureolus Paracelsus von Hohenheim) All is poison, nothing is without poison; only the dose determines what is not a poison

3 Methyl mercury toxicity Fetal toxicity Paresthesia Ataxia Prevalence, % Dysarthria Deafness 20? Methyl mercury in hair, mg/kg Death WHO (1990), EHC 101

4 Basic concepts Some chemicals produce local effects Most chemicals produce systemic effects effects do not occur at the site of first contact Require absorption and distribution to a distant site where the effects are produced Most chemicals are metabolised before excretion Adverse effects are usually observed in one or two organs (target organs)

5 ADME Chemicals Skin Lung Gastrointestinal tract Absorption Distribution Metabolism Other tissues Blood Liver Excretion Kidney Hair Breast milk Urine Faeces

6 Biotransformation Lipohilic Hydrophilic

7 Biotransformation of paracetamol Lethal dose g - or even less Within hours: nausea, vomiting, pallor, sweating Between 24 and 72 hours: signs of increasing liver damage, possibly kidney failure At 3 to 5 days: massive hepatic necrosis, kidney failure, multiple organ failure, and death.

8 Hazard Class Acute Toxicity Oral Dermal Inhalation Skin Corrosion/Irritation Serious Eye Damage/Irritation Sensitization Respiratory Skin Germ Cell Mutagenicity Carcinogenicity Reproductive Toxicity STOT - Single Exposure STOT - Repeated Exposure Aspiration hazard Health hazards Hazard Category Corrosive 1A 1B 1C 1A 1A Decrease in severity 1A 1B 2 1A 1B 2 1A 1B Irritant A 2B 1B 1B Lactation

9 Acute toxicity Single exposure High dose Clinical symptoms Treatment Recovery Chronic toxicity Repeated exposure Low dose No overt clinical symptoms Treatment not always possible Sustained/irreversible damage

10 Weight of evidence Human epidemiological studies Human case reports Toxicity testing, in vivo studies Toxicity testing, in vitro mammalian cell assays Non-testing methods

11

12 Acute oral and dermal toxicity: LD50: Dose causing death in 50% of the treated animals following single exposure via oral or dermal route. Dose causing evident toxicity Preferred species rat and rat/rabbit. Acute toxiciy 100% Lethality 50% LD50 Acute inhalation toxicity: LC50: Concentration causing death in 50% of the treated animals following 4 hours of exposure by inhalation. Preferred species rat. GHS distinguishes between exposure to dust, mist, gas and vapour Dose Note: Present OECD TG do not have lethality (LD50, LC50) as an endpoint

13 Inhalation Classification criteria: Acute toxicity Exposure Route Oral (mg/kg bw) Dermal (mg/kg/bw) Gases (ppmv) Vapours (mg/l) Dust/mists (mg/l) Category 1 Category 2 Category 3 Category 4 Category 5 ATE 5 5 < ATE < ATE < ATE < ATE 5000 ATE < ATE < ATE < ATE < ATE 5000 ATE < ATE < ATE < ATE ATE < ATE < ATE < ATE 20 ATE < ATE < ATE < ATE 5 Equivalent to oral or dermal route Equivalent to oral or dermal route Equivalent to oral or dermal route ATE = acute toxicity estimate

14 Acute Toxic Class Method (OECD TG 423) Recommended starting dose GHS Cat.1 >0-5 GHS Cat.2 >5-50 GHS Cat.3 > GHS Cat.4 > GHS Cat.5 > Category 5 or Unclassified

15 Classification of a mixture: acute oral toxicity Concentration ATE Classification Substance 1 1% 225 mg/kg Substance 2 3% 100 mg/kg Substance 3 10% acute tox, cat 3 Water 86% Note: The relevant ingredients to be considered when classifying a mixture for acute toxicity are those present at 1%

16 Additivity formula for classification of a mixture based on the acute toxicity of the ingredients 1) Data available for all ingredients 100 ATE mixture n Ci ATEi C i i n ATE i = concentration of ingredient i (% w/w or % v/v) = the individual ingredient from 1 to n = the number of ingredients = Acute Toxicity Estimate of ingredient i

17 Inhalation Conversion from range value/category to point estimate Exposure Route Oral (mg/kg bw) Category or experimental estimate 0 < category < category < category < category < category Dermal (mg/kg/bw) 0 < category < category < category < category < category Gases (ppmv) Vapours (mg/l) 0 < category < category < category < category Category 5 equivalent 0 < category 1 0,.5 0,5 < category 2 2,.0 2,0 < category < category 4 20 Category 5 equivalent Dust/mists (mg/l) 0 < category 1 0, < category < category < category 4 5 Category 5 equivalent Converted point estimate

18 Classification of a mixture: acute oral toxicity Concentration ATE Classification Substance 1 1% 225 mg/kg Substance 2 3% 100 mg/kg Substance 3 10% mg/kg Water 86% 100 ATE mixture = ATE mixture n Ci ATEi acute tox, cat 3 ATE mixture = 743 Point estimate: 100 classification: acute tox, cat 4

19 Additivity formula for classification of a mixture based on the acute toxicity of the ingredients 2) Data not available for all ingredients 100 C unknownif 10% ATE mixture n C i ATE i C i i n ATE i = concentration of ingredient i (% w/w eller % v/v) = the individual ingredient from 1 to n = the number of ingredients = Acute Toxicity Estimate for ingredient i

20 Label elements Category 1 Category 2 Category 3 Category 4 Category 5 Oral H300: Fatal if swallowed H300: Fatal if swallowed H301: Toxic if swallowed H302: Harmful if swallowed H303: May be harmful if swallowed Dermal H310: Fatal in contact with skin H310: Fatal in contact with skin H311: Toxic in contact with skin H312: Harmful in contact with skin H313: May be harmful in contact with skin Inhalation H330: Fatal if inhaled H330: Fatal if inhaled H331: Toxic if inhaled H332: Harmful if inhaled H333: May be harmful if inhaled Danger Danger Danger Warning Warning

21 Skin corrosion/irritation Skin corrosion: Irreversible damage dermal exposure Skin irritation: Damage showing reversibility within 14 days after treatment

22 Skin corrosion/irritation category 1: Corrosive Corrosive* in 1 of 3 animals Sub-category Exposure Observation 1A 3 minutes 1 hour 1B > 3 min to 1 hour 14 days 1C > 1 hour to 4 hours 14 days *visible necrosis through the epidermis and into the dermis

23 Skin corrosion/irritation Category 2: Irritant Category 3: Mild irritant Criteria a) Mean value of for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 or 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or b) Inflammation that persists to the end of the observation period (normally 14 days) in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or c) In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above. Mean value of for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 or 72 hours or, if reactions are delayed, from grades Not on in 3 consecutive CLP days after the onset of skin reactions (when not included in the irritant category above)

24 Grading of skin reactions (OECD TG 404) Erythema and Eschar Formation No erythema 0 Very slight erythema (barely perceptible) 1 Well defined erythema 2 Moderate to severe erythema 3 Severe erythema (beef redness) to eschar formation preventing grading of erythema 4 Oedema Formation Maximum possible: 4 No oedema 0 Very slight oedema (barely perceptible) 1 Slight oedema (edges of area well defined by definite raising) 2 Moderate oedema (raised approximately 1 mm) 3 Severe oedema (raised >1 mm and extending beyond area of exposure) 4 Maximum possible: 4

25 Test results (OECD TG 404) Animal no. Degree of erythema after Degree of oedema after Mean 24/48/72h 2.3? 1h 24h 48h 72h 7d 1h 24h 48h 72h 7d Erythema Oedema Mean score = 2.7 Mean score = 2.0 Yes No Mean score = 3 Mean score = 1.7 Yes No Mean score = 0.66 Mean score = 1.0 No No 2/3 positive responders (exceeding mean score 2.3 for erythema) Skin Irritant Category 2

26 Classification of a mixture: skin corrosion/irritation Sum of ingredients classified as: Concentration triggering classification of a mixture as: Skin Corrosive Category 1* Skin Irritant Category 2 Skin Irritant Category 3 Skin Category 1 5% 1% but < 5% Skin Category 2 10% 1% but < 10% Skin Category 3 10% (10 x Skin Category 1) + Skin Category 2 (10 x Skin Category 1) + Skin Category 2 + Skin Category 3 10% 1% but < 10% 10% *If sub-categories are used: The sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C, respectively, should each be 5% in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5% but the sum of Category 1A+1B ingredients is 5%, the mixture should be classified as Skin Corrosive Category 1B. If the sum of the Skin Corrosive Category 1A+1B ingredients is < 5% but the sum of of Category 1A+1B+1C ingredients is 5% the mixture should be classified as Skin Corrosive Category 1C.

27 Classification of a mixture when the additivity approach does not apply Ingredient Concentration Mixture classified as: Skin Acid with ph 2 1% Category 1 Base with ph 11.5% 1% Category 1 Other corrosive (Category 1) ingredient 1% Category 1 Other irritant (Category 2/3) ingredient, including acids and bases. 3% Category 2

28 Label elements Category 1 Category 2 Category 3 Category 1A Category 1B Category 1C H314: Causes severe skin burns and eye damage H315: Causes skin irritation H316: Causes mild skin irritation Danger Warning Warning

29 Serious eye damage/eye irritation Serious eye damage: Not fully reversible damage (decay of vision) following single topical exposure Eye irritation: full reversibility within 21 days after treatment

30 Serious eye damage Category 1: Irreversible effects on the eye Criteria If, when applied to the eye of an animal, a substance produces: At least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or At least in 2 of 3 tested animals, a positve response of: Corneal opacity 3 and/or iritis > 1.5 calculated as the mean score following grading at 24, 48 and 72 hours after instillation of the test material

31 Reversible effects on the eye Category 2A: Irritating to eyes Category 2B: Mildly irritating to eyes Criteria If, when applied to the eye of an animal, a substance produces: At least in 2 of 3 tested animals, a positive response of: Corneal opacity 1; and/or iritis > 1; and/or conjunctival redness 2; and/or conjunctival oedema (chemosis) 2 calculated as the mean score following grading at 24, 48 and 72 hours after instillation of the test material, and which fully reverses within an observation period of normally 21 days. When the effects listed above are fully reversible within 7 days of observation. Not in CLP

32 Classification of a mixture: serious eye damage/eye irritation Sum of ingredients classified as: Concentration triggering classification of a mixture as: Serious eye damage Eye irritation Category 1 Category 2/2A Skin Category 1 + Eye Category 1 a 3% 1% but < 3% Eye Category 2 10 x (skin Category 1 + eye category 1) a + eye Category 2 10% b 10% a If an ingredient is classified as both skin Category 1 and eye Category 1 its concentration is considered only once in the calculation b A mixture may be classified as eye Category 2B when all relevant ingredients are classified as eye Category 2B

33 Classification of a mixture when the additivity approach does not apply Ingredient Concentration Mixture classified as: Eye Acid with ph 2 1% Category 1 Base with ph 11.5% 1% Category 1 Other corrosive (eye Category 1) ingredient Other eye irritant (eye Category 2) ingredient 1% Category 1 3% Category 2

34 Label elements Category 1 Category 2A Category 2B H318: Causes serious eye damage H319: Causes serious eye irritation H320: Causes eye irritation Danger Warning Warning

35 Aspiration toxicity Entry of a liquid or solid chemical product directly through the oral or nasal cavity, or from vomiting, into the trachea and lower respiratory system. May result in chemical pneumonia and varying degrees of pulmonary injury which may be fatal Physicochemical properties Human experience No test method available

36 Aspiration toxicity Category Category 1 Category 2 Criteria Chemicals known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazard. A substance is classified in Category 1: a) Based on reliable and good quality human evidence, or b) If it is a hydrocarbon and has a kinematic viscosity of 20.5 mm 2 /s, measured at 40 C Chemicals which cause concern owing to the presumption that they cause human aspiration toxicity hazard. Not in CLP On the basis of existing animal studies and expert judgement that takes into account surface tension, water solubility, boiling point, and volatility, substances, other than those classified in Category 1, which have a kinematic viscosity 14 mm 2 /s, measured at 40 C

37 Classification of a mixture:aspiration toxicity Category 1 A mixture which contains a total of 10% of a substance or substances classified in Category 1, and has a kinematic viscosity of 20.5 mm 2 /s measured at vid 40 C A mixture which separates into two or more distinct layers, one of which contains 10% of a substance classified in Category 1 and has a kinematic viscosity of 20,5 mm 2 /s measured at 40 C Category 2* A mixture which contains a total of 10% of a substance or substances classified in Category 2, and has a kinematic viscosity of 14 mm 2 /s measured at vid 40 C A mixture which separates into two or more distinct layers, one of which contains 10% of a substance classified in Category 1 and has a kinematic viscosity of 14 mm 2 /s measured at 40 C *The use of expert judgement that considers surface tension, water solubility, boiling point, volatility is critical, especially when Category 2 substances are mixed with water

38 Label elements Category 1 Category 2 H304: May be fatal if swallowed and enters airways H305: May be harmful if swallowed and enters airways Danger Warning

39 Allergy An adverse immune reaction to a protein (or allergen) that develops after repeated exposure to the causative agent. Sensitisation (induction of specialised immunological memory) takes place on initial exposure to an allergen during which time no adverse reaction appears. Elicitation is the reaction provoked by repeated exposure to the allergen

40 Sensitisation Skin sensitisation: Evidence for an immunological reaction (e.g. erythema, oedema, contact urticaria) in humans or test animals. Respiratory sensitisation: Asthma in exposed humans; consider size of exposure (number of people and concentration). Currently no test system available. Other: Rhinitis conjunctivitis alveolitis

41 Sensitisation Adaptive immune responses are systemic in nature; skin sensitisation does not result only from dermal exposure respiratory sensitisation requires protection of both skin and respiratory tract ingestion of allergen can induce respiratory effects

42 Immune response Type 1 Type 4 Immediate Antibody-mediated Allergic rhinitis Bronchial asthma Urticaria (hives) Delayed Cell-mediated Inflammatory response

43 Respiratory sensitisation Category 1 Sub-category 1A Subcategory 1B Criteria A substance is classified as a respiratory sensitizer: a) If there is evidence in humans that the substance can lead to specific respiratory hypersensitivity, and/or b) If there are positive results from an appropriate animal test* Substances showing a high frequency of occurrence in humans; or a probability of occurrence of a high sensitization rate in humans based on animal or other tests. Severity of reaction may also be considered Substances showing a low to moderate frequency of occurrence in humans; or a probability of occurrence of a low to moderate sensitization rate in humans based on animal or other tests. Severity of reaction may also be considered *presently there are no recognized and validated animal models available

44 Classification of a mixture: respiratory sensitisation Ingredient classified as: Respiratory sensitizer Category 1 Respiratory sensitizer Sub-category 1A Respiratory sensitizer Sub-category 1B Concentration triggering classification of a mixture as: Solid/Liquid Respiratory Sensitizer Category 1 Gas 0.1%* 0.1%* 1.0% 0.2% 0.1% 0.1% 1.0% 0.2% *Some competent authorities may require SDS and/or supplemental labelling for mixtures containing a sensitizing ingredient above this concentration

45 Skin sensitisation Category 1 Sub-category 1A Subcategory 1B Criteria A substance is classified as a skin sensitizer: a) If there is evidence in humans that the substance can lead sensitization by skin contact in a substantial number of persons, or b) If there are positive results from an appropriate animal test Substances showing a high frequency of occurrence in humans and/or a high potency in animals can be presumed to have the potential to produce significant sensitization in humans. Severity of reaction may also be considered Substances showing a low to moderate frequency of occurrence in humans and/or a low to moderate potency in animals can be presumed to have the potential to produce sensitization in humans. Severity of reaction may also be considered

46 Classification of a mixture: skin sensitisation Ingredient classified as: Skin sensitizer Category 1 Skin sensitizer Sub-category 1A Skin sensitizer Sub-category 1B Concentration triggering classification of a mixture as: Skin sensitizer Category 1 0.1%* 1.0% 0.1% 1.0% *Some competent authorities may require SDS and/or supplemental labelling for mixtures containing a sensitizing ingredient above this concentration

47 Label elements Respiratory sensitization Category 1/1A/1B H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled Skin sensitization Category 1/1A/1B H317: May cause an allergic skin reaction Danger Warning

48 Specific target organ toxicity (STOT)

49 STOT single exposure Category Category 1 Category 2 Criteria Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposure. Substances are classified in Category 1on the basis of: a) Reliable and good quality evidence from human cases or epidemiological studies; or b) Observations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposure. Substances are classified in Category 2 on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. In exceptional cases, human evidence can also be used to place a substance in Category 2.

50 STOT single exposure Supporting classification Not supporting classification Substance-related deaths Major functional changes in the central or peripheral nervous systems (sight, hearing, sense of smell) or other organ systems (for example the lung) Severe disturbances (eg haematological disturbances suggesting that they are due to decreased bone marrow production of blood cells) Severe organ damage, especially heart, nervous system, stem cell populations Only change in body weight gain, food consumption or water intake Small changes (clin chem) which are of doubtful or minimal toxicological importance Changes in organ weights with no evidence of organ dysfuntion Adaptive responses (enzyme induction, liver hypotrophy, macrophage migration in the lung) Species-specific mechanism

51 STOT single exposure: Guidance values Route of exposure Guidance value ranges for:* Unit Category 1 Category 2 Category 3 Oral (rat) mg/kg bw C < C 2000 Dermal (rat or rabbit) Inhalation (rat) gas Inhalation (rat) vapour Inhalation (rat) dust/mist/fume mg/kg bw C < C 2000 ppmv/4h C < C mg/l/4h C < C 20 mg/l/4h C < C 5.0 Guidance values do not apply (based on human data) *The guidance values are intended for guidance purposes to be used as part of the weight-of-evidence approach and to assist in decision about classification. They are not intended as strict demarcation values.

52 STOT single exposure Category Category 3 Transient target organ effects Criteria This category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversly alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function.

53 Classification of a mixture: STOT SE Ingredient classified as: Generic concentration limits triggering classification of the mixture as: Category 1 Category 2 Category 1 STOT 1.0% a 1.0 C < 10% c 10% b Category 2 STOT 1.0% a - 10% b a between 1.0 and 10% an SDS would be required. A label may be required in some jurisdictions b at a concentration of 10% both an SDS and a label would generally be expected c if a Category 1 STOT ingredient is present between 1.0 and 10%, some authorities classify the mixture as STOT 2

54 Label elements Category 1 Category 2 Category 3 H370: Causes damage to organs H371: May cause damage to organs H335: May cause respiratory irritation or H336: may cause drowsiness or dizziness Danger Warning Warning

55 STOT repeated exposure Category Category 1 Category 2 Criteria Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure. Substances are classified in Category 1 on the basis of: a) Reliable and good quality evidence from human cases or epidemiological studies; or b) Observations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations.. Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure. Substances are classified in Category 2 on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. In exceptional cases, human evidence can also be used to place a substance in Category 2

56 STOT repeated exposure: Guidance values Guidance value ranges for:* Route of exposure Unit Category 1 Category 2 Oral (rat) mg/kg bw/day C < C 100 Dermal (rat or rabbit) Inhalation (rat) gas Inhalation (rat) vapour Inhalation (rat) dust/mist/fume mg/kg bw/day C < C 200 ppmv/6h/day C < C 250 mg/l/6h/day C < C 1.0 mg/l/6h/day C < C 0.2 *The guidance values are intended for guidance purposes to be used as part of the weight-of-evidence approach and to assist in decision about classification. They are not intended as strict demarcation values.

57 Classification of a mixture STOT RE Ingredient classified as: Generic concentration limits triggering classification of the mixture as: Category 1 Category 2 Category 1 STOT 1.0% a 1.0 C < 10% c 10% b Category 2 STOT 1.0% a - 10% b a between 1.0 and 10% an SDS would be required. A label may be required in some jurisdictions b at a concentration of 10% both an SDS and a label would generally be expected c if a Category 1 STOT ingredient is present between 1.0 and 10%, some authorities classify the mixture as STOT 2

58 Label elements Category 1 Category 2 H372: Causes damage to organs through prolonged or repeated exposure H373: May cause damage to organs through prolonged or repeated exposure Danger Warning

59 Genotoxicity

60 Definitions Mutation: a permanent change in the amount or structure of the genetic material in a cell In germ cells genetic damage can be transferred to the next generation (via sperms, eggs) In somatic cells genetic damage can be transferred to daughter cells (e.g. in the liver, skin) Mutagen: an agent that gives rise to an increased occurence of mutations in populations of cells and/or organisms Genotoxicity: applies to agents or processes which alter the structure, information content or segregation of DNA, including replication processes

61 Reverse mutation

62 Chromosome abberrations (in vitro; mammalian cells): Large deletions and rearrangements Unequal partition of chromosomes between daughter cells (nondisjunction) Sister chromatid exchange

63 Category 1 Category 1A Germ cell mutagenicity Criteria Substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans. Substances known to induce heritable mutations in germ cells of humans Classification is based on positive evidence from human epidemiological studies. Category 1B Substances to be regarded as if they induce heritable mutations in the germ cells of humans. Classification in Category 1B is based on: Positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or Positive result(s) from in vivo somatic cell mutagenicity test in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or Positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneploidy in sperm cells of exposed people.

64 Germ cell mutagenicity Category 2 Criteria Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans Classification in Category 2 is based on: Positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from: Somatic cell mutagenicity tests in vivo, in mammals; or Other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays. Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, should be considered for classfication as Category 2 mutagens.

65 Classification of a mixture: Germ cell mutagenicity Ingredient classified as: Concentration limits triggering classification of a mixture as: Category 1A mutagen Category 1B mutagen Category 1A mutagen 0.1% - Category 1B mutagen - 0.1% Category 2 mutagen Category 2 mutagen % -

66 Label elements Category 1A Category 1B Category 2 H340: May cause genetic defects H341: Suspected of causing genetic defects Danger Warning

67 Carcinogenicity Evidence that exposure increases the incidence of tumours Non-threshold Genotoxic carcinogens Threshold Non-genotoxic carcinogens

68 Normal cell DNA damage Multistage carcinogenesis Apoptosis (programmed cell death) Mutagen Repair Initiation Initiated Mutations cell Promotion Neoplastic Angiogenesis cell Progression Tumour

69 Important factors to consider Confounding effects of excessive toxicity localized effects Effects only at very high dose levels exceeding Maximal Tolerated Dose (MTD) (e.g. >10% retardation in weight gain) Specific tumour types e.g. forestomach tumours following administration by gavage of an irritating or corrosive, non-mutagenic chemical Unusual tumour types or tumours occuring with reduced latency may add to the weight of evidence (even if not statistically significant) Unique mechanism e.g. lack of human relevance of kidney tumours in male rats associated with compounds causing kidney damage (α-2-microglobulin nephropathy)

70 Carcinogenicity testing Duration months (mice or rats) Male and female animals 1-2 Control groups 3 dose groups 50 animals/group animals total

71 Category Category 1 Category 1A Category 1B Carcinogenicity Criteria Known or presumed human carcinogens A substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as: Known to have carcinogenic potential for humans, classification is largely based on human evidence Presumed to have carcinogenic potential for humans, classification is largely based on animal evidence The classification in Category 1A or 1B is based on strength of evidence together with additional considerations. Such evidence may be derived from: Human studies that establish a casual relationship between human exposure to a substance and the development of cancer (known human carcinogen); or Animal experiments for which there is sufficient evidence to demonstrate animal carcinogenicity (presumed human carcinogen) In addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.

72 Carcinogenicity Category Category 2 Suspected human carcinogen Criteria The placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1, based on strength of evidence together with additional considerations. Such evidence may be derived either from limited evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.

73 Classification of a mixture: Carcinogenicity Ingredient classified as: Concentration limits triggering classification of a mixture as: Category 1 carcinogen Category 2 carcinogen Category 1A Category 1B Category 1A carcinogen 0.1% - Category 1B carcinogen - 0.1% Category 2 carcinogen %* 1.0%** *If a Category 2 carcinogen is present in the mixture at a concentration between 0.1 and 1.0% an SDS would be required. A label may be required in some jurisdictions **If a Category 2 carcinogen is present in the mixture at a concentration of 1.0% both an SDS and a label would generally be expected

74 Label elements Category 1A Category 1B Category 2 H350: May cause cancer H351: Suspected of causing cancer Danger Warning

75 Reproductive toxicity

76 Reproductive toxicity Effects on fertility Genetic changes in germ cells Infertility Alterations in sex hormone levels Ovarian dysfunction Sexual behaviour Effects on development Growth Organ and tissue development and function Acquisition of normal organ function between conception and puberty May cause Death (in utero or postnatally) Structural defects Growth retardation Functional defects E.g. neurodevelopment Childhood cancer Confounder: maternal toxicity

77 WHO/UNEP (2013): State of the Science of Endocrine Disrupting Chemicals 2012

78 Reproductive toxicity Category Criteria Category 1 Known or presumed human reproductive toxicant Category 1A Category 1B Substances are classified in Category 1 for reprodutive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development, in humans, or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data or from animal data. Known human reproductive toxicant Largely based on evidence from humans Presumed human reproductive toxicant Largely based on data from animal studies. Data should provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occuring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.

79 Reproductive toxicity Category Category 2 Criteria Suspected human reproductive toxicant Substances are classified in Category 2 for reproductive toxicity when there is some evidence from human or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1 The effects should have been observed in the absence of other toxic effects, or if occuring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.

80 Additional category Effects on or via lactation Effects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effetcs on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metablites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, should be classified and labelled to indicate this property hazardous to breastfed babies. This classifiaction can be assigned on the basis of: a) Human evidence indicating a hazard to babies during the lactation period; and/or b) Results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effects on the quality of the milk; and/or c) Absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk.

81 Classification of a mixture: reproduction toxicity Ingredient classified as: Category 1A reproductive toxicant Concentration limits triggering classification of a mixture as: Category 1 reproductive toxicant Category 1A Category 1B Category 2 reproductive toxicant Effects on or via lactation 0.1% a % b Category 1B reproductive toxicant - 0.1% a - 0.3% b Category 2 reproductive toxicant % c - 3.0% d Effects on or via lactation a between 0.1 and 0.3% an SDS would be required. A label may be required in some jurisdictions b at a concentration of 0.3% both an SDS and a label would generally be expected c between 0.1 and 3.0% an SDS would be required. A label may be required in some jurisdictions d at a concentration of 3.0% both an SDS and a label would generally be expected 0.1% a 0.3% b

82 Label elements Category 1A Category 1B Category 2 Additional category H360: May damage fertility or the unborn child H361: Suspected of damaging fertility or the unborn child H362: May cause harm to breast-fed children Danger Warning

83 Highly Hazardous Pesticides Working definition by FAO/WHO Joint Meeting* WHO: Classes 1a or 1b GHS: Mutagenicity Cat. 1A or 1B GHS: Carcinogenicity Cat. 1A or 1B GHS: Reproductive toxicity Cat. 1A or 1B Stockholm Convention: Annex A or B or Annex D, para 1 Montreal protocol High incidence of severe or irreversible adverse effects *

84 Some hot topics in toxicology Endocrine disruptors Combined exposures ( cocktail effect ) Non-monotonic dose-response Nanomaterials Non-animal testing

85 Some useful links OECD: Test guidelines: Health effects ECHA: Classification and Labelling Inventory database echemportal: The OECD Global Portal to Information on Chemical Substances

86 Thank you for your attention

Human Health Classification: General Considerations and Overview

Human Health Classification: General Considerations and Overview Human Health Classification: General Considerations and Overview 1 Key considerations for GHS Classifications Focuses on Self Classification by industry Identify Physical State e.g., metal salt, oxide,

More information

Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Health and environmental hazards Classification criteria for substances and mixtures Working definitions Substance: Chemical

More information

DRAFT. Comparison between EU and GHS Criteria. Human Health and Environment

DRAFT. Comparison between EU and GHS Criteria. Human Health and Environment DRAFT Comparison between and Human Health and Environment The comparison is based on the ST/SG/AC.10/30/Rev2 2007 This comparison of the current classification system and the is a draft working document

More information

Substances for health hazards

Substances for health hazards Classification and Labelling of Substances for health hazards Identification of informationen GHS/CLP does not foresee the use of uniform test methods Different test methods - as long as they are scientifically

More information

1 of 27 11/20/2012 9:07 AM

1 of 27 11/20/2012 9:07 AM 1 of 27 11/20/2012 9:07 AM A to Z Index En español Contact Us FAQs About OSHA OSHA Newsletter RSS Feeds Print This Page Text Size Was this page helpful? What's New Offices Home Workers Regulations Enforcement

More information

PART 3 HEALTH HAZARDS

PART 3 HEALTH HAZARDS PART 3 HEALTH HAZARDS - 107 - CHAPTER 3.1 ACUTE TOXICITY 3.1.1 Definition Acute toxicity refers to those adverse effects occurring following oral or dermal administration of a single dose of a substance,

More information

GHS data for solutions

GHS data for solutions GHS data for solutions Experimental data for solutions are available for relatively few chemicals, apart from the most common industrial chemicals, such as sodium hydroxide and sulfuric acid. In the absence

More information

Properties criteria - BASTA

Properties criteria - BASTA Properties criteria - BASTA - according to Regulation (EC) No. 1272/2008 (CLP) VALID FROM 2018-07-01 Introduction The aim of the BASTA system is to phase out substances with particularly hazardous properties

More information

The Globally Harmonized System of Hazard Classification and Labelling of Chemicals: Critical Aspects for Metals: Human Health

The Globally Harmonized System of Hazard Classification and Labelling of Chemicals: Critical Aspects for Metals: Human Health The Globally Harmonized System of Hazard Classification and Labelling of Chemicals: Critical Aspects for Metals: Human Health Prepared By Bill Adams (Rio Tinto) & Hugo Waeterschoot (EINA) February 13,

More information

INTRODUCTION TO THE GHS

INTRODUCTION TO THE GHS INTRODUCTION TO THE GHS SAFETY HEALTH & WELLBEING CONTENTS Contents... 1 1 Introduction... 2 2 Purpose... 2 3 Background... 2 4 What is the GHS?... 2 4.1 GHS hazard communication... 3 4.2 GHS pictograms...

More information

Appendix A. Substance Classification and Labelling under REACH

Appendix A. Substance Classification and Labelling under REACH Appendix A Substance Classification and Labelling under REACH Classification and labelling are used to communicate hazards associated with substances through their use on packaging and in safety data sheets.

More information

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48.

Substance Evaluation Conclusion document EC No SUBSTANCE EVALUATION CONCLUSION DOCUMENT. as required by REACH Article 48. SUBSTANCE EVALUATION CONCLUSION DOCUMENT as required by REACH Article 48 for Butanone oxime EC No 202-496-6 CAS No 96-29-7 Evaluating Member State(s): Germany Dated: 18 March 2014 Evaluating Member State

More information

Information Source List Type High (H) Moderate (M) Low (L) GHS Category 1A (Known) or 1B (Presumed) for any route of exposure

Information Source List Type High (H) Moderate (M) Low (L) GHS Category 1A (Known) or 1B (Presumed) for any route of exposure Carcinogenicity (C) Mutagenicity/Genotoxicity (M) List High (H) Moderate (M) Low (L) GHS Category 1A (Known) or 1B (Presumed) for any route of exposure GHS Category 2 (Suspected) for any route of exposure

More information

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM ANNEX AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM Annex AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM A.1 Classification proposal The following classification proposal

More information

Schedule. - Expectations and Goals/objectives. - Back to Basics. - Terms and Definitions. - Non-additive Hazards. - Additive Hazards

Schedule. - Expectations and Goals/objectives. - Back to Basics. - Terms and Definitions. - Non-additive Hazards. - Additive Hazards GHS in SDS Understanding CLP (GHS) Classification and Calculations Yvonne Jansma, implementation consultant at Sphera and associated with Preventpartner Schedule - Expectations and Goals/objectives - Back

More information

Hazard Communication Standard Contents

Hazard Communication Standard Contents Hazard Communication Standard Contents C.4.19 FLAMMABLE LIQUIDS (Classified in Accordance with Appendix B.6) Hazard category Signal word Hazard statement 1 Danger Extremely flammable liquid and vapor

More information

s Page 1 of 2 Summary of and Labelling Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation) General Information Index Number EC Number CAS Number International Chemical

More information

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM - 427 - Annex 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM A8.1 Classification proposal The following classification

More information

Hazard statements (H)

Hazard statements (H) Hazard statements (H) H200 H201 H202 H203 H204 H205 H220 H221 H222 H223 H224 H225 H226 H228 H240 H241 H242 H250 H251 H252 Unstable explosive. Explosive; mass explosion hazard. Explosive; severe projection

More information

Reproductive toxicity classification under CLP (Regulation (EC) no 1272/2008 on Classification, Labelling and Packaging of chemicals)

Reproductive toxicity classification under CLP (Regulation (EC) no 1272/2008 on Classification, Labelling and Packaging of chemicals) Reproductive toxicity classification under CLP (Regulation (EC) no 1272/2008 on Classification, Labelling and Packaging of chemicals) A satellite workshop to the 45th Annual Meeting of the European Teratology

More information

: TETRACYCLINE HYDROCHLORIDE CRS

: TETRACYCLINE HYDROCHLORIDE CRS Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 10/12/2009 Version: 7.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product

More information

5.15 HEXYTHIAZOX (176)

5.15 HEXYTHIAZOX (176) Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox

More information

Toxicology. Toxicity. Human Health Concerns. Health Effects of Hazardous Materials

Toxicology. Toxicity. Human Health Concerns. Health Effects of Hazardous Materials Human Health Concerns Health Effects of Hazardous Materials Toxicology Study of the nature, effects, and detection of poisons in organisms Humans are obvious focal point Other species and ecosystem function

More information

Dithianon DITHIANON (180)

Dithianon DITHIANON (180) Dithianon 201 5.11 DITHIANON (180) TOXICOLOGY Dithianon (C 14 H 4 N 2 O 2 S 2 ) is the International Organization for Standardization (ISO) approved name for 5,10-dihydro-5,10-dioxonaphtho[2,3-b]-1,4-dithiine-2,3-dicarbonitrile

More information

Safety Data Sheet. KHA300 INTERTUF 262 OFF WHITE PART A Version Number 2 Revision Date 05/14/18

Safety Data Sheet. KHA300 INTERTUF 262 OFF WHITE PART A Version Number 2 Revision Date 05/14/18 International Paint Singapore Pte Ltd Safety Data Sheet KHA300 INTERTUF 262 OFF WHITE PART A Version Number 2 Revision Date 05/14/18 1. Product and company identification 1.1. Product identifier INTERTUF

More information

: Pro 1 Oil Supplement

: Pro 1 Oil Supplement Date of issue: 03/18/2016 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Product name : Mixture Product code : 93400

More information

: SikaForce B Part B

: SikaForce B Part B SECTION 1: Identification of the hazardous chemical and of the supplier Product name : Product code : 000000611895 Type of product : liquid Manufacturer or supplier's details Company : Sika Kimia Sdn.

More information

: Aeliteflo. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

: Aeliteflo. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification Date of issue: 12/03/2014 Revision date: 02/19/2015 Version: 1.1 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Product name : Mixture

More information

Comments CLH proposal Cadmium hydroxide

Comments CLH proposal Cadmium hydroxide 1 Comments CLH proposal Cadmium hydroxide GENERAL COMMENTS: The International Cadmium association (ICdA) welcomes the opportunity to provide its contribution to the public consultation on the proposed

More information

: Whitecap Contractor Strength

: Whitecap Contractor Strength SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name : Whitecap Contractor Strength 1.2. Relevant identified uses of the substance or mixture

More information

SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification Date of issue: 12/03/2014 Revision date: 02/19/2015 Version: 1.1 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form: Mixture Product

More information

: Aelite Aesthetic Enamel

: Aelite Aesthetic Enamel SECTION 1: Identification 1.1. Identification Product form Product name Aelite Aesthetic Enamel Date of issue: 01/19/2018 Version: 1.0 : Mixture 1.2. Recommended use and restrictions on use Use of the

More information

TheraCem Base SECTION 1: Identification 1.2. Relevant identified uses of the substance or mixture and uses advised against

TheraCem Base SECTION 1: Identification 1.2. Relevant identified uses of the substance or mixture and uses advised against SECTION 1: Identification 1.1. Identification Product form Product name TheraCem Base Date of issue: 01/20/2017 Version: 2 : Mixture : TheraCem Base 1.2. Relevant identified uses of the substance or mixture

More information

SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use

SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use SECTION 1: Identification 1.1. Identification Product form Product name : Mixture : GoTo 1.2. Recommended use and restrictions on use Use of the substance/mixture 1.3. Supplier : For Rx Only Manufacturer

More information

: Duo-Link Base. SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use

: Duo-Link Base. SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use SECTION 1: Identification 1.1. Identification Product form Product name Duo-Link Base Date of issue: 01/03/2018 Version: 2.0 : Mixture 1.2. Recommended use and restrictions on use Use of the substance/mixture

More information

RINSE ALL. Restrictions on Use None known. Manufacturer Esteam Mfg Ltd, th NE, Calgary, Alberta, T2E6V2, , esteam.

RINSE ALL. Restrictions on Use None known. Manufacturer Esteam Mfg Ltd, th NE, Calgary, Alberta, T2E6V2, , esteam. Safety Data Sheet RINSE ALL SECTION 1. IDENTIFICATION Product Identifier Other Means of Identification RINSE ALL ECLEAN RINSE ALL Product Family mixture Recommended Use Acidic Rinse Agent. Restrictions

More information

Part 2. Chemical and physical aspects

Part 2. Chemical and physical aspects Part 2. Chemical and physical aspects 12. Chemical and physical aspects: introduction 12.1 Background information used The assessment of the toxicity of drinking-water contaminants has been made on the

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

OIL, CINNAMON STICKS*

OIL, CINNAMON STICKS* Date of issue: 08/28/2017 Revision date: 08/28/2017 Version: 1.0 SECTION 1: Identification 1.1. Identification Product form Product name : Mixture : OIL, CINNAMON STICKS* 1.2. Recommended use and restrictions

More information

SECTION 1: Identification. SECTION 2: Hazard(s) identification. SECTION 3: Composition/Information on ingredients. 1.1.

SECTION 1: Identification. SECTION 2: Hazard(s) identification. SECTION 3: Composition/Information on ingredients. 1.1. Date of issue: 1/17/2018 Version: 8 SECTION 1: Identification 1.1. Identification Product form Product name : Mixture : O.V.S. (Ortho Veneer System) Pastes 1.2. Recommended use and restrictions on use

More information

: Penetreat. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

: Penetreat. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification Date of issue: 08/28/2015 Revision date: 10/20/2015 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product code EPA

More information

: MEPROBAMATE CRS. Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

: MEPROBAMATE CRS. Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 16/12/2009 Version: 5.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier

More information

EURL ECVAM TEMPLATE FOR CLASSIFICATION OF CHEMICALS FOR SERIOUS EYE DAMAGE / EYE IRRITATION FROM IN VIVO DRAIZE EYE TEST DATA Explanatory document

EURL ECVAM TEMPLATE FOR CLASSIFICATION OF CHEMICALS FOR SERIOUS EYE DAMAGE / EYE IRRITATION FROM IN VIVO DRAIZE EYE TEST DATA Explanatory document EURL ECVAM TEMPLATE FOR CLASSIFICATION OF CHEMICALS FOR SERIOUS EYE DAMAGE / EYE IRRITATION FROM IN VIVO DRAIZE EYE TEST DATA Explanatory document Els Adriaens, João Barroso, Chantra Eskes and Sebastian

More information

5.36 THIOPHANATE-METHYL (077)

5.36 THIOPHANATE-METHYL (077) 391 5.36 THIOPHANATE-METHYL (077) TOXICOLOGY is the International Organization for Standardization (ISO) approved common name for dimethyl 4,4 -(o-phenylene)bis(3-thioallophanate) (International Union

More information

Triple Threat Safety Data Sheet

Triple Threat Safety Data Sheet SECTION 1: Product and company identification Product name : Triple Threat Use of the substance/mixture : Herbicide Product code : 0363 Company : Total Solutions P.O. Box 240014 Milwaukee, WI 53224 - USA

More information

Product: H12MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No )

Product: H12MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No ) February 013 Properties, Hazards and Safety Information for H1MDI* Product: H1MDI (4,4 -Methylene dicyclohexyl diisocyanate; CAS No. 514-30-1) Physical and chemical data Physical state liquid Colour colourless

More information

: SikaTop Armatec -110 EpoCem Part B

: SikaTop Armatec -110 EpoCem Part B SECTION 1: Identification of the hazardous chemical and of the supplier Product name : Product code : 000000022218 Type of product : liquid Recommended use of the chemical and restrictions on use Product

More information

SOFTSOAP LIQUID HAND SOAP ANTISEPTIC

SOFTSOAP LIQUID HAND SOAP ANTISEPTIC SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Product code : 200000029129 : B02913790001 Manufacturer or supplier's details Company : Colgate-Palmolive Co 300 Park Avenue New York, NY 10022

More information

Effect of Concentration on Hazard Classification

Effect of Concentration on Hazard Classification Effect of Concentration on Hazard Classification Taken from Schedule 3, Part II, The Chemicals (Hazard Information and Packaging for Supply) Regulations 2002 Note There are official classifications for

More information

CLASSIFICATION AND LABELLING

CLASSIFICATION AND LABELLING CLASSIFICATION AND LABELLING 1. Classification and labelling according to CLP / GHS Name: Cement copper Implementation: EU State/form of the substance: moist residue Related composition: Cement copper

More information

: Meropenem for Injection

: Meropenem for Injection SECTION 1: Identification 1.1. Identification Product name : Meropenem for Injection Other means of identification : NDC CODE: 55150-207-20, 55150-208-30 (for 500 mg, 1g) 1.2. Relevant identified uses

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Substance name : Substance : Salicylic acid

More information

Product: IPDI (Isophorone diisocyanate; CAS No )

Product: IPDI (Isophorone diisocyanate; CAS No ) November 2015 Properties, Hazards and Safety Information for IPDI* Product: IPDI (Isophorone diisocyanate; CAS No. 4098-71-9) Physical and chemical data Physical state liquid Colour colourless to yellowish

More information

Proteinase K Solution

Proteinase K Solution Safety Data Sheet SECTION 1. IDENTIFICATION Product Identifier Other Means of Identification Other Identification Product Family Recommended Use Restrictions on Use Manufacturer / Supplier Emergency Phone

More information

HEALTH HAZARDS WHEN GETTING IN CONTACT WITH CHEMICALS

HEALTH HAZARDS WHEN GETTING IN CONTACT WITH CHEMICALS HEALTH HAZARDS WHEN GETTING IN CONTACT WITH CHEMICALS The ancient Civilizations already knew the effects for human health of certain chemical substances To poison their enemies In the XVIII century some

More information

Safety Data Sheet. EK9Q10 INTERGARD 744 YELLOW LC PART A Version Number 1 Revision Date 11/27/13. For professional use only.

Safety Data Sheet. EK9Q10 INTERGARD 744 YELLOW LC PART A Version Number 1 Revision Date 11/27/13. For professional use only. PT. International Paint Indonesia Safety Data Sheet EK9Q10 INTERGARD 744 YELLOW LC PART A Version Number 1 Revision Date 11/27/13 1. Product and company identification 1.1. Product identifier INTERGARD

More information

SASE SFS SPR3. Safety Data Sheet. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

SASE SFS SPR3. Safety Data Sheet. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification SASE SASE SFS SPR3 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name. : SASE SFS SPR3 1.2. Relevant identified uses of the substance

More information

: Bis-Core Base. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

: Bis-Core Base. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification Date of issue: 12/03/2014 Revision date: 02/06/2015 Version: 1.1 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Product name : Mixture

More information

: Sweat Controls for Cystic Fibrosis Testing

: Sweat Controls for Cystic Fibrosis Testing SECTION 1: Identification 1.1. Identification Product form Product name Product code : Mixture : Sweat Controls for Cystic Fibrosis Testing : SS-150 1.2. Relevant identified uses of the substance or mixture

More information

: FLUVASTATIN SODIUM CRS

: FLUVASTATIN SODIUM CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 27/11/2009 Version: 3.0 SECTION 1: Identification of the substance/mixture

More information

Safety Data Sheet. EK9E05 INTERGARD 744 ORANGE LC PART A Version Number 1 Revision Date 11/27/13. For professional use only.

Safety Data Sheet. EK9E05 INTERGARD 744 ORANGE LC PART A Version Number 1 Revision Date 11/27/13. For professional use only. PT. International Paint Indonesia Safety Data Sheet EK9E05 INTERGARD 744 ORANGE LC PART A Version Number 1 Revision Date 11/27/13 1. Product and company identification 1.1. Product identifier INTERGARD

More information

: Reveal HD Bulk. SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use

: Reveal HD Bulk. SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use SECTION 1: Identification 1.1. Identification Product form Product name Reveal HD Bulk Date of issue: 12/07/2017 Version: 1.0 : Mixture 1.2. Recommended use and restrictions on use Use of the substance/mixture

More information

: Resinomer Catalyst. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

: Resinomer Catalyst. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification Date of issue: 11/25/2014 Revision date: 03/06/2015 Version: 1.1 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product form Product name : Mixture

More information

: TRIAMCINOLONE HEXACETONIDE CRS

: TRIAMCINOLONE HEXACETONIDE CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 14/12/2009 Version: 5.0 SECTION 1: Identification of the substance/mixture

More information

: BENZYL ALCOHOL CRS

: BENZYL ALCOHOL CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 04/02/2010 Version: 5.0 SECTION 1: Identification of the substance/mixture

More information

Material Safety Data Sheet CleanCart -C. 1 Identification of the substance and of the company

Material Safety Data Sheet CleanCart -C. 1 Identification of the substance and of the company 1 Identification of the substance and of the company 1.1 Product identifier Product name CleanCart -C 1.2 Relevant identified uses of the substance and uses advised against Identified use Cleaning of the

More information

: PANTOPRAZOLE SODIUM SESQUIHYDRATE CRS

: PANTOPRAZOLE SODIUM SESQUIHYDRATE CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 25/11/2009 Version: 6.0 SECTION 1: Identification of the substance/mixture

More information

: POWER SHOT UNI PRO BORIC INSECTICIDE DUST

: POWER SHOT UNI PRO BORIC INSECTICIDE DUST Date of issue: 05/20/2015 Revision date: 05/20/2015 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product code : :

More information

: Esomeprazole Sodium for Injection

: Esomeprazole Sodium for Injection SECTION 1: Identification 1.1. Identification Product name Other means of identification : Esomeprazole Sodium for Injection : NDC 55150-184-05 (20 mg) NDC 55150-185-05 (40 mg) 1.2. Relevant identified

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier

More information

Dichlorvos DICHLORVOS (025)

Dichlorvos DICHLORVOS (025) Dichlorvos 63 5.7 DICHLORVOS (025) TOXICOLOGY Dichlorvos is the International Organization for Standardization (ISO) approved common name for 2,2-dichlorovinyl dimethyl phosphate (International Union of

More information

: Duo-Link Universal Base

: Duo-Link Universal Base SECTION 1: Identification 1.1. Identification Product form Product name Duo-Link Universal Base Date of issue: 03/02/2018 Version: 2.0 : Mixture 1.2. Recommended use and restrictions on use Use of the

More information

SSS Urinal Screen With Block, Evergreen

SSS Urinal Screen With Block, Evergreen Safety Data Sheet SECTION 1. IDENTIFICATION Product Identifier Other Means of Identification Other Identification Product Family Recommended Use Restrictions on Use Supplier Emergency Phone No. SDS No.

More information

Annex to a news release

Annex to a news release Annex to ECHA News 1 (5) 15 June 2018 Annex to a news release Helsinki, 15 June 2018 SEAC adopted one restriction proposal Lead and its compounds in shot SEAC adopted its final opinion, in support of the

More information

Use of TTC and Human Relevance George E. N. Kass, PhD

Use of TTC and Human Relevance George E. N. Kass, PhD Use of TTC and Human Relevance George E. N. Kass, PhD Future Challenges in Developing Assessment Methodologies for Human Health Effects Tokyo, 14 November 2018 Disclaimer The views, thoughts and opinions

More information

Selective Herbicide #3 Broadleaf Weed Killer Safety Data Sheet

Selective Herbicide #3 Broadleaf Weed Killer Safety Data Sheet SECTION 1: Product and company identification Product name : Use of the substance/mixture : Herbicide Product code : 0360 Company : Athea Laboratories, Inc. P.O. Box 240014 Milwaukee, WI 53224 - USA T

More information

5.17 PENTHIOPYRAD (253)

5.17 PENTHIOPYRAD (253) Penthiopyrad 189 5.17 PENTHIOPYRAD (253) TOXICOLOGY Penthiopyrad is the International Organization for Standardization (ISO) approved name for N-[2- (1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide

More information

SAFETY DATA SHEET BICOWHITE COMPLEX. SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product Identifier BW_S3

SAFETY DATA SHEET BICOWHITE COMPLEX. SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product Identifier BW_S3 Pag. 1/9 SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1 Product Identifier Code 1.2 Relevant identified uses of the substances or mixture and uses

More information

: LISINOPRIL DIHYDRATE CRS

: LISINOPRIL DIHYDRATE CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 04/02/2010 Version: 5.0 SECTION 1: Identification of the substance/mixture

More information

Substance name: Ammonium Dichromate EC number: CAS number: MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF

Substance name: Ammonium Dichromate EC number: CAS number: MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF Substance name: Ammonium Dichromate EC number: 232-143-1 CAS number: 7789-09-5 MEMBER STATE COMMITTEE SUPPORT DOCUMENT FOR IDENTIFICATION OF AMMONIUM DICHROMATE AS A SUBSTANCE OF VERY HIGH CONCERN BECAUSE

More information

: THIOCTIC ACID CONTAINING IMPURITY B CRS

: THIOCTIC ACID CONTAINING IMPURITY B CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 17/12/2009 Version: 4.0 SECTION 1: Identification of the substance/mixture

More information

(Non-legislative acts) REGULATIONS

(Non-legislative acts) REGULATIONS 30.3.2011 EN Official Journal of the European Union L 83/1 II (Non-legislative acts) REGULATIONS COMMISSION REGULATION (EU) No 286/2011 of 10 March 2011 amending, for the purposes of its adaptation to

More information

: Liquid Bicarbonate Concentrate

: Liquid Bicarbonate Concentrate Date of issue: 03/02/2017 Revision date: 03/02/2017 Version : 1.0 SECTION 1: Identification 1.1. Identification Product name Product code : : BC-1-L RENASOL Liquid Bicarbonate MB-330-L CENTRISOL Liquid

More information

: ARGININE HYDROCHLORIDE CRS

: ARGININE HYDROCHLORIDE CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 25/11/2009 Version: 7.0 SECTION 1: Identification of the substance/mixture

More information

SAFETY DATA SHEET SECTION 1 - IDENTIFICATION

SAFETY DATA SHEET SECTION 1 - IDENTIFICATION SAFETY DATA SHEET SECTION 1 - IDENTIFICATION Product Identifier: RP-OCNF LIFT STATION DEGREASER Recommended Use: RED SOLVENT LIFT STATION DEGREASER Restrictions on Use: INDUSTRIAL OR PROFESSIONAL USE ONLY

More information

: SALBUTAMOL SULFATE CRS

: SALBUTAMOL SULFATE CRS Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 04/02/2010 Version: 6.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product

More information

: GLYCEROL FORMAL CRS

: GLYCEROL FORMAL CRS in accordance with Regulation (EC) No. 1907/2006, as amended. Date of issue: 27/06/2013 Revision date: 27/06/2013 Supersedes: 14/12/2011 Version: 1.0 SECTION 1: Identification of the substance/mixture

More information

SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification Evergreen A-44 Cleaner-Degreaser Date of issue: 05/27/2015 Revision date: 05/27/2015 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier

More information

GPS Safety Summary - TOLUENE

GPS Safety Summary - TOLUENE GPS Safety Summary - TOLUENE SUBSTANCE NAME TOLUENE CHEMICAL IDENTITY Name: TOLUENE Chemical name (IUPAC): TOLUENE CAS number: 108-88-3 EC number: 203-625-9 Molecular formula: C 7 H 8 Structure: USES AND

More information

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP)

Risk Assessment Report on Tris (nonylphenyl)phosphite (TNPP) EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER

More information

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.

Safety Data Sheet Safety Data Sheet in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1. in accordance with regulation (EC) No 1907/2006, as amended. Date of issue: 31/05/2017 Version: 1.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier

More information

: Benefect Botanical Impact Cleaner

: Benefect Botanical Impact Cleaner Date of issue: 05/26/2015 Revision date: 05/12/2017 Version: 2.0 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product code : :

More information

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Page: 1 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Ashland Regulatory Information Number 1-800-325-3751 P.O. Box 2219 Telephone 614-790-3333 Columbus, OH 43216 Emergency

More information

SAFETY DATA SHEET <#####> PERMECTRIN II Version 2.0 Revision Date 07/30/2015

SAFETY DATA SHEET <#####> PERMECTRIN II Version 2.0 Revision Date 07/30/2015 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING Product information Product Name: SDS Number: 122000008520 Use : Pesticide Company BAYER HEALTHCARE LLC Animal Health Division

More information

Product Identification Numbers

Product Identification Numbers Safety Data Sheet Copyright,2017,3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing 3M products is allowed provided that: (1) the information

More information

Sodium Dichromate (VI) Anhydrous

Sodium Dichromate (VI) Anhydrous Revision date 08-04-2016 1.1 Product identifier Sodium Dichromate (VI) Section 1: Identification of the substance/ mixture and of the company/ undertaking. Product name Other names Sodium Dichromate (VI)

More information